How long does bupropion remain in the body of a healthy adult taking a therapeutic extended‑release dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Long Bupropion Stays in Your System

Bupropion has an elimination half-life of approximately 21 hours, meaning it takes roughly 4–5 days (about 5 half-lives) for the drug to be essentially cleared from your body after stopping. However, its active metabolites persist significantly longer—hydroxybupropion has a half-life of approximately 20 hours, while threohydrobupropion and erythrohydrobupropion have half-lives of approximately 37 and 33 hours, respectively, requiring 7–9 days for complete elimination. 1, 2

Parent Drug Elimination

  • Bupropion itself reaches steady-state plasma concentrations within 8 days of chronic dosing and has a mean elimination half-life of 21 hours (±9 hours). 1
  • After a single 100 mg oral dose in healthy volunteers, the elimination half-life ranged from 8 to 16.5 hours, with some variability between individuals. 3, 4, 5
  • Following the standard "5 half-lives to clearance" pharmacokinetic principle, bupropion is eliminated from plasma in approximately 4–5 days after the last dose. 1, 2

Active Metabolite Persistence

  • Hydroxybupropion, the primary active metabolite formed via CYP2B6, has an elimination half-life of approximately 20 hours (±5 hours), requiring roughly 4–5 days for clearance. 1, 2
  • Threohydrobupropion and erythrohydrobupropion have significantly longer half-lives of approximately 37 hours (±13 hours) and 33 hours (±10 hours), respectively, meaning these metabolites persist for 7–9 days after discontinuation. 1, 2, 5
  • At steady state, hydroxybupropion concentrations are 4- to 7-fold higher than bupropion at peak, with an AUC approximately 10- to 13-fold greater than the parent drug. 1, 2
  • Threohydrobupropion reaches steady-state AUC levels 7 times that of bupropion, while erythrohydrobupropion reaches 1.4 times that of bupropion. 1

Clinical Implications of Metabolite Activity

  • Hydroxybupropion retains approximately 50% of bupropion's pharmacologic activity, while threohydrobupropion and erythrohydrobupropion retain approximately 20% activity based on animal models. 2
  • Because metabolite plasma concentrations are as high or higher than bupropion itself, the clinical effects of bupropion may persist for up to 7–9 days after the last dose due to lingering active metabolites. 1, 2

Special Population Considerations

Hepatic Impairment

  • In patients with alcoholic liver disease, the elimination half-life of the morpholinol metabolite (hydroxybupropion) is significantly prolonged to 32.2 hours (±13.5 hours) compared to 21.1 hours (±4.9 hours) in healthy subjects, extending clearance time to 6–7 days for this metabolite. 4
  • Mean AUC values for bupropion and all metabolites are increased in hepatic impairment, though high inter-individual variability makes precise predictions difficult. 4

Pediatric Patients

  • In youths aged 11–17 years, bupropion has a significantly shorter mean half-life of 12.1 hours compared to adults (21 hours), suggesting faster clearance in approximately 2.5–3 days. 6
  • However, threohydrobupropion half-life in youths is 26.3 hours, still shorter than the 37 hours observed in adults, but metabolite-to-parent AUC ratios are 19–80% higher in youths, indicating relatively greater metabolite accumulation. 6

Practical Timeline Summary

For a healthy adult on therapeutic extended-release dosing:

  • Bupropion parent drug: Essentially cleared in 4–5 days 1, 2
  • Hydroxybupropion: Cleared in 4–5 days 1, 2
  • Threohydrobupropion and erythrohydrobupropion: Cleared in 7–9 days 1, 2, 5
  • Complete system clearance (all active compounds): Approximately 7–9 days after the last dose 1, 2, 5

Important Caveats

  • Only 0.5% of an oral bupropion dose is excreted unchanged in urine; 87% is recovered as metabolites in urine and 10% in feces, meaning renal and hepatic function significantly impact clearance. 1
  • Factors altering metabolic capacity—including liver disease, congestive heart failure, age, and concomitant medications—will prolong elimination times for both bupropion and its metabolites. 1
  • Drug interaction considerations persist for approximately 7–9 days after stopping bupropion, particularly for medications metabolized by CYP2D6 (which bupropion inhibits) or CYP2B6 (which metabolizes bupropion). 1, 2

Related Questions

What is the elimination time of Wellbutrin (bupropion) from the system?
What is the half-life of bupropion (Wellbutrin)
What is the recommended dosage and administration schedule for Bupropion (Bupropion) Hydrochloride XL?
Can bupropion (Wellbutrin) be started in a patient who is currently taking amitriptyline, aspirin, atorvastatin, azithromycin, diltiazem, cetirizine, ergocalciferol (vitamin D2), estradiol cream, hydrochlorothiazide, hydrocortisone cream, levothyroxine, montelukast, nicotine patches, omeprazole, pantoprazole, clopidogrel, tizanidine, and triamcinolone cream?
Does bupropion require dose adjustment in an adult with a serum creatinine of 1.3 mg/dL?
In an uncomplicated adult after vesicoureteric junction (VUJ) incision with cautery to remove a large stone, how long should the ureteral stent remain in place?
What are the possible causes of fever in a patient with lung cancer receiving targeted therapy (e.g., EGFR, ALK, ROS1, or BRAF/MEK inhibitors)?
What is the best multivitamin‑mineral supplement for a generally healthy adult with a varied diet?
What is the appropriate diagnostic work‑up and first‑line treatment for acute pericarditis in an adult presenting with sharp chest pain that worsens when lying flat and improves when sitting up?
Why am I experiencing immediate sedation and falling asleep within 15 minutes of taking extended‑release methylphenidate, even after doubling the dose, and what should I do?
What is the recommended antibiotic regimen and duration for an adult with normal renal function who has a Pseudomonas aeruginosa infection that is susceptible to piperacillin‑tazobactam and resistant to meropenem?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.